1. Home
  2. LOOP vs TLSA Comparison

LOOP vs TLSA Comparison

Compare LOOP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$0.98

Market Cap

58.1M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.51

Market Cap

182.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
TLSA
Founded
2010
2013
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
182.7M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
LOOP
TLSA
Price
$0.98
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
71.6K
420.5K
Earning Date
01-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,112,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$41.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10901.98
N/A
52 Week Low
$0.85
$0.63
52 Week High
$2.29
$2.60

Technical Indicators

Market Signals
Indicator
LOOP
TLSA
Relative Strength Index (RSI) 41.44 42.23
Support Level $0.95 $1.45
Resistance Level $1.01 $1.62
Average True Range (ATR) 0.07 0.16
MACD 0.01 -0.01
Stochastic Oscillator 47.83 44.23

Price Performance

Historical Comparison
LOOP
TLSA

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: